Intervention Review

Vigabatrin for refractory partial epilepsy

  1. Karla Hemming1,*,
  2. Melissa J Maguire2,
  3. Jane L Hutton3,
  4. Anthony G Marson4

Editorial Group: Cochrane Epilepsy Group

Published Online: 31 JAN 2013

Assessed as up-to-date: 4 DEC 2012

DOI: 10.1002/14651858.CD007302.pub2

How to Cite

Hemming K, Maguire MJ, Hutton JL, Marson AG. Vigabatrin for refractory partial epilepsy. Cochrane Database of Systematic Reviews 2013, Issue 1. Art. No.: CD007302. DOI: 10.1002/14651858.CD007302.pub2.

Author Information

  1. 1

    University of Birmingham, Public Health, Epidemiology and Biostatistics, Birmingham, UK

  2. 2

    Leeds General Infirmary, Neurology, Leeds, UK

  3. 3

    University of Warwick, Department of Statistics, Coventry, UK

  4. 4

    Institute of Translational Medicine, University of Liverpool, Department of Molecular and Clinical Pharmacology, Liverpool, Merseyside, UK

*Karla Hemming, Public Health, Epidemiology and Biostatistics, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 31 JAN 2013


Options for accessing this content:

  • If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
  • Login via other institutional login options
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens


Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.